EMA Withdrawn: Lamivudine/Zidovudine Teva (lamivudine;zidovudine) — Teva Pharma B.V.

View source ↗

Summary

The EMA has withdrawn Lamivudine/Zidovudine Teva (lamivudine; zidovudine) from the market.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• Lamivudine/Zidovudine Teva (lamivudine; zidovudine)

Snippet

Status: Withdrawn. Therapeutic area: HIV Infections. MAH: Teva Pharma B.V.. Decision date: 21/03/2022